Impact of Ondansetron Timing on Symptom Burden and Diagnostic Performance During Pediatric Growth Hormone Stimulation Testing
Ondansetron does not affect GH test outcomes and may reduce symptoms. BMI standard deviation scores (SDS) is an independent predictor of GH response and should be considered in interpreting test results.
Authors
- Luigi Garibaldi (ORCID: https://orcid.org/0000-0001-9415-1915)
- Erika McCann
- Emir Tas (ORCID: https://orcid.org/0000-0003-3759-2778)
- Wassim Chemaitilly (ORCID: https://orcid.org/0000-0003-0717-5076)
- Oscar Escobar (ORCID: https://orcid.org/0009-0008-5830-2569)
- Swetha Movva
- Katrina Stumbras
- Elizabeth Ranella
Publication Details
- Journal
- Journal of Pediatric Health Care
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1016/j.pedhc.2025.09.001
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00